Breast Reduction Vertical Incision in Rio de Janeiro BR
Breast reduction is an operation that is usually considered a reconstructive procedure and is many times covered by insurance plans. The surgery is performed to make the breasts smaller, as well as lift the breasts to a more youthful position. The purpose of the surgery is to alleviate back and neck pain as well as to aid in hygiene in the folds underneath the breasts.
Marks are made on the skin according to the type of reduction planned by the patient and the surgeon. This is usually performed before the patient is taken back to the operating room with the patient in a sitting or standing position.
With the patient now asleep, incisions are made around the predetermined marks on the breasts.
The breast tissue is removed with an electro cautery instrument that cauterizes bleeding vessels while it removes the breast tissue. This helps reduce the amount of blood that is lost during the operation.
The incisions are closed with sutures.
The patient is placed in a compression garment or bra. Compression garments are an important part of the recovery process. The garment provides support, comfort and helps to minimize swelling. The patient is usually wearing a bra or some type of supportive garment at all times, except when showering. Healing time is approximately three months. Scarring is variable and often depends on the patient's ability to heal.
More Rio de Janeiro info...
Rio de Janeiro By taxi
A cab is one of the best ways to move around Rio. All legal cabs are yellow with a blue stripe painted on the sides. Taxis not designed like this are special service cars (to the airport or bus stations) or illegal. Rio has some of the cheapest taxi systems in the world, so don't bother spending a little more in exchange of speed and safety. Most of the tours in the South Zone will cost around R$15, and the car can usually hold four people. You can ask a cab for a city tour, and arrange a fixed price (may be around US$20). Major taxi companies include Central de Taxi, Ouro Taxi and Yellow Taxi.
After getting into the taxi, check to see if the taximeter has been started (as of December 2006, it charges R$ 4.30 for the minimum ride, called bandeirada). If not, ask the taxi driver to do so. You may be ripped off by some taxi drivers. Avoid the blue, green, and white taxis as they tend to charge considerably more for the same ride.
-
Plastic Surgery News...
- A Canadian observational study has examined the influence of rheumatoid arthritis (RA) treatments on the risk of haematological malignant neoplasms (HMN). The study used data from administrative databases on a cohort of 23,810 patients in Quebec from January 1980, to December 2003. Case patients were those with a HMN; they were matched for age and sex with 10 control subjects. After adjustment for clinical variables and concomitant medications, an analysis was conducted of potential associations between DMARD exposures and risk for HMN. The study reported that HMN developed in 619 patients, including lymphomas in 346 patients, leukaemia in 178 patients, and multiple myelomas in 95 patients. The unadjusted rate ratios for HMN after drug exposures were:
• Methotrexate, 1.18 (95% CI, 0.99 to 1.40)
• Azathioprine, 1.44 (1.01 to 2.03)
• Cyclophosphamide, 2.21 (1.52 to 3.20)
The adjusted estimates suggested that haematological cancer risk was most elevated after exposure to cyclophosphamide (1.84; 95% CI, 1.24 to 2.73) and the corresponding figure for lymphomas after cyclophosphamide exposure was 2.12 (1.33 to 3.54). There were insufficient exposures to biologic agents, which did not appear in the Quebec formulary until 2002, for an analysis of these agents to be conducted.
The researchers note that controversy continues as to how much of the total risk of HMN in RA is related to the disease process itself compared with immunosuppressants; recent data suggest both aspects are likely important. They conclude from these current findings that cyclophosphamide was associated with the greatest relative risk for HMN and they advise that assessments of risk related to newer and emerging therapies should carefully consider previous and concomitant medication exposures.
- On Feb. 15 Reporters met with four of America's foremost nanotechnology experts at Boston Marriott Copley Place, Suffolk Room, 110 Huntington Avenue, Boston, Mass.for a wide-ranging discussion about using the technology to more effectively treat patients and to better produce and secure energy.